Ground Swell Capital’s Utah Medical Products UTMD Stock Holding History

Ground Swell Capital’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$19K	Buy	+385	New	+$19.6K	0.04%	562

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

MDCM

Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ground Swell Capital's UTMD Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Utah Medical Products (UTMD) in Q3 2014: 385 shares worth $19K. The stake represents 0.04% of the portfolio and ranks #562 among its holdings.

62 funds tracked by Wall St. Rank hold UTMD as of Q3 2014.

Ground Swell Capital held 385 shares of Utah Medical Products worth $19K as of Q3 2014.
Utah Medical Products was a new Ground Swell Capital position in Q3 2014.
Utah Medical Products made up 0.04% of Ground Swell Capital's portfolio in Q3 2014, its #562 holding.
62 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.